Author

T. Galla

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Organism:bacteria (other)· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

E. Berrios-Caro· 3 shared D. R. Gifford· 2 shared A. Bhattacharyya· 1 shared C. G. Knight· 1 shared C. Joerres· 1 shared G. W. A. Constable· 1 shared J. Forsyth· 1 shared M. Sune· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersEvolutionary Biology

E. Berrios-Caro

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mutators drive evolution of multi-resistance to antibiotics

D. R. Gifford, E. Berrios-Caro, C. Joerres, M. Sune, J. Forsyth, A. Bhattacharyya, T. Galla, C. G. Knight

This study shows that mutator bacteria can evolve multi-drug resistance under both single-drug and combination antibiotic treatments, undermining the effectiveness of combination therapy.

bioRxiv · Sep 10, 2022 · PreprintEvolutionary Biology

Switching environments, synchronous sex, and the evolution of mating types

E. Berrios-Caro, T. Galla, G. W. A. Constable

This paper develops a model of synchronous environmental switching to study the evolution of mating types in populations, finding deviations from previous asynchronous theories under slow switching.

bioRxiv · Jul 31, 2020Evolutionary Biology

Competition delays multi-drug resistance evolution during combination therapy

E. Berrios-Caro, D. R. Gifford, T. Galla

This study shows that competition between resistant strains affects the emergence of drug resistance, particularly for double resistance, and suggests that exponential growth models may overestimate resistance risks.

bioRxiv · May 27, 2020Evolutionary Biology